| Sarah Ann Hester Memorial Home | |
| 407 Dakota Street, Benkelman, Nebraska 69021 | |
| (308) 423-2179 | |
| Name | Sarah Ann Hester Memorial Home |
|---|---|
| Location | 407 Dakota Street, Benkelman, Nebraska |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 56 |
| Occupancy Rate | 31.43% |
| Medicare ID (CCN) | 285241 |
| Legal Business Name | Sarah Ann Hester Memorial Home |
| Ownership Type | For Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Eight days. That's how long it takes for skin cells to reprogram into red blood cells. Researchers at Lund University in Sweden, together with colleagues at Center of Regenerative Medicine in Barcelona, have successfully identified the four genetic keys that unlock the genetic code of skin cells and reprogram them to start producing red blood cells instead.
A computer system was more effective than doctors at collecting information about patient symptoms, producing reports that were more complete, organized and useful than narratives generated by physicians during office visits, according to a Cedars-Sinai study.
Natural HIV-1 infection does not always elicit a protective immune response, according to a new study published November 16 in PLoS Pathogens.
PharmaMar announced today the start of a phase III study for the anticancer agent PM1183 in patients with platinum-resistant ovarian cancer (PROC). Once study objectives are met, the CORAIL trial (NCT02421588) will be used to support the regulatory filing of PM1183 as treatment for this indication.
Teva Pharmaceutical Industries Ltd. announced today enrollment of the first patient in the MODERATO study - a Phase IV clinical study designed to evaluate the effect of AZILECT (rasagiline tablets) on cognitive function in adults with mild cognitive impairment (MCI) in Parkinson's disease (PD-MCI).
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $655 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 10.26 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.33 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 53.57 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.95 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 9.21 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.1 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 25.61 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 0 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 37.04 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 29.63 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 0 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 100 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 0 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 0 | 82.93 |
News Archive
Eight days. That's how long it takes for skin cells to reprogram into red blood cells. Researchers at Lund University in Sweden, together with colleagues at Center of Regenerative Medicine in Barcelona, have successfully identified the four genetic keys that unlock the genetic code of skin cells and reprogram them to start producing red blood cells instead.
A computer system was more effective than doctors at collecting information about patient symptoms, producing reports that were more complete, organized and useful than narratives generated by physicians during office visits, according to a Cedars-Sinai study.
Natural HIV-1 infection does not always elicit a protective immune response, according to a new study published November 16 in PLoS Pathogens.
PharmaMar announced today the start of a phase III study for the anticancer agent PM1183 in patients with platinum-resistant ovarian cancer (PROC). Once study objectives are met, the CORAIL trial (NCT02421588) will be used to support the regulatory filing of PM1183 as treatment for this indication.
Teva Pharmaceutical Industries Ltd. announced today enrollment of the first patient in the MODERATO study - a Phase IV clinical study designed to evaluate the effect of AZILECT (rasagiline tablets) on cognitive function in adults with mild cognitive impairment (MCI) in Parkinson's disease (PD-MCI).
› Verified 8 days ago
Sarah Ann Hester Memorial Home Location: 407 Dakota Street, Benkelman, Nebraska 69021 Phone: (308) 423-2179 |